Hydrogel and nanoparticle carriers for kidney disease therapy: trends and recent advancements.

Achieving local therapeutic agent concentration in the kidneys through traditional systemic administration routes have associated concerns with off-target drug effects and toxicity. Additionally, kidney diseases are often accompanied by co-morbiditie…

Preview only. Read the full abstract at the source